Why Support WMC XI 2027

For Corporate Partners

  • Dedicated industry-sponsored symposia to highlight the latest products, technologies, and diagnostics supporting the management of melioidosis.
  • Unique exposure to key Asia-Pacific and global markets where melioidosis is endemic.
  • Increased opportunities for partnership with leading research institutions, hospitals, and public health organisations.

For Healthcare Providers

  • Participate as part of sub-specialty training for clinicians in infectious diseases, microbiology, internal medicine, critical care, paediatrics, and public health.
  • Gain up-to-date knowledge on the latest advances in clinical management, diagnostics, and therapeutics.
  • Engage in plenary sessions, symposia, and case-based discussions led by international experts.
  • Present your research and innovations through poster and oral presentations, fostering scientific exchange.

For Policy Maker

  • Unique opportunity to engage with leading global experts in melioidosis and related infectious diseases.
  • Platform to discuss strategies for surveillance, prevention, and control in both human and animal health.
  • Networking forum with clinicians, researchers, and industry partners to strengthen national and regional responses.

Ready to Exhibit?

Drop an email to ongj@kenes.com or complete the form below and our team will be in touch with available packages and opportunities.